0 followers
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Kleanthis G. Xanthopoulos
Kyverna Therapeutics
7 followers
A-Alpha Bio
1 follower
UNC Charlotte
6 followers
Vaxcyte
2 followers
Mirum Pharmaceuticals
3 followers
Adaptive Biotechnologies
14 followers
Slingshot Biosciences
1 follower
Priovant
2 followers
Generate Biomedicines
3 followers
Strand Therapeutics
3 followers
Lisata Therapeutics
1 follower
Explore companies